OCV

TORL BioTherapeutics is a clinical-stage biopharmaceutical business focused on creating innovative, antibody-based medicines to improve the lives of cancer patients. They are developing a comprehensive pipeline of innovative preclinical ADCs and mAb in oncologic diseases with high unmet medical needs.

Ozette Technologies specializes in digitizing biology using machine learning to give an entire view of an individual’s immune system. By digitizing immune data, they accelerate the discovery and development of therapies and diagnostics.

Ockam is simple. There are three things you need to know: First, we enable you to build trust between every application, database, SaaS service, code repo, data lake, AI Engine, container, and microservice... everywhere, in any network. Second, Ockam is networkless. We enable you to skip the pain of system administration, IP Backlogs, Allow Lists, VPNs, firewalls, reverse proxies, setting up public endpoints, creating public APIs, and key administration. And third, Ockam is secure-by-design. It is open-source, audited and built in rust. It does the encryption, authentication, key generation, rotation, revocation, and a lot more. For more information, please visit www.ockam.io.

Rad AI develops an artificial intelligence automated report generation platform to automate repetitive tasks for radiologists. Its platform integrates with existing workflow, automating repetitive tasks, and enabling radiologists to improve radiology workflow that maximizes efficiency and accuracy while reducing burnout for radiologists and improving patient care.

ByHeart operates as a fully integrated infant nutrition company. It is dedicated to translating leading nutrition science and breastmilk research into evolved foods and formulas to support babies’ health and parents’ peace of mind. Its products strive to be next to nature made from hand-picked ingredients using small-batch blending and sit at the forefront of immune, microbiome, cognitive, and digestive health. The company was founded in 2016 and is headquartered in New York.

Founded in 2018 by a team of Navy veterans, Orca AI, a maritime tech startup, empowers shipping companies to enhance their operational safety, efficiency, and sustainability through a single AI and computer-vision-based operations platform. By October 2024, 900 vessels have been booked, and 550 installations have already been completed. The platform is trusted by key industry players across various shipping segments, including MSC, Seaspan, Maran Tankers / Angelicoussis Group, NYK, and Marubeni. The company has raised a total of $38 million in funding over two rounds from US, UK, and Israeli VCs and employs 80 people across its offices in London, Athens, Singapore, and Tel Aviv.

Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.

Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain.

SafeBreach is a pioneer in the emerging category of breach and attack simulation. The company's groundbreaking platform provides a “hacker's view” of an enterprise’s security posture to proactively predict attacks, validate security controls and improve SOC analyst response. SafeBreach automatically executes breach methods with an extensive and growing Hacker’s Playbook of research and real-world investigative data. SafeBreach is funded by Sequoia Capital, Deutsche Telekom Capital, Hewlett Packard Pathfinder and investor Shlomo Kramer.

ByHeart operates as a fully integrated infant nutrition company. It is dedicated to translating leading nutrition science and breastmilk research into evolved foods and formulas to support babies’ health and parents’ peace of mind. Its products strive to be next to nature made from hand-picked ingredients using small-batch blending and sit at the forefront of immune, microbiome, cognitive, and digestive health. The company was founded in 2016 and is headquartered in New York.

Finch Therapeutics is a mission-driven microbiome engineering company, is developing novel microbial therapies to serve patients with serious and unmet medical needs. The company uses machine learning algorithms to reverse engineer successful fecal transplantations and other clinical datasets, identifying the microbes that drive responses in patients. This human-centric discovery model leverages clinical data to focus on in-vitro and in-vivo efforts on cocktails of microbes that have already demonstrated safety and efficacy in humans. This enables early retirement of translational risk and avoids the challenges of extrapolating host-specific effects from animal models. Finch Therapeutics was founded in 2017 and is headquartered in Somerville, Massachusetts.

Figure8​ is an experience-first development company to realize, recognize, and reignite relationships with the people and places around them. The company is built on core tenets of imagination, connection, and creativity. Figure8 was founded by Manish Vora and Maryellis Bunn in 2016 and is headquartered in New York, USA.

OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Their vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology. OSSIOfiber represents a breakthrough material platform for orthopedic and podiatric surgeons who seek a more biologically friendly way to restore patient stability and mobility with nothing permanent left behind. Founded in 2014, OSSIO began as the culmination of years of biomechanical research and a vision for the possibility of better bone healing. The technological basis of OSSIOfiber™ was developed and would lay the groundwork for ushering in a new breakthrough category of non-permanent fixation, “Bio-Integratives” hardware that has both desired strength AND bio-friendliness. Hardware that has the mechanical strength for easy insertion and secure fixation, while enabling the body to regrow bone, incorporating and replacing the implant (without the adverse inflammation and weakness often seen in “bio-resorbables and other “bio-composites”), has remained elusive to the industry until now.

Invoice2go’s mission is to simplify the lives of small business owners around the world so they can focus on what matters most. Invoice2go is the world’s leading technology company helping freelancers and small businesses run their business their way. Simple from start to finish, Invoice2go gives users the tools they need to deliver winning estimates and invoices, manage appointments, track jobs, and offer clients the ability to pay any way. These features, and more, help users stay organized, look and feel professional, and win more jobs so they can continue to grow their business. Invoice2go was founded by a small business owner who came from a family of tradespeople, and wanted to help streamline their business. Today, we're backed by $60 million in funding from Accel, Ribbit Capital and OCV Partners. More than 210,000 small business owners in 160+ countries use the app to send $24 billion in invoices every year. Our world-class team in Redwood City, California and Sydney, Australia comprises of alumni of companies like PayPal, Dropbox, Yahoo, McKinsey, Xero, Magento, Morgan Stanley, JP Morgan Chase, and Visa. We’re proud of the product we’re building and are always looking for talented people to join our team! Check out our open roles and get in touch today.

Precision BioSciences is a biotechnology company dedicated to improving lives through its next-generation gene editing technology, ARCUS. Precision BioSciences’ mission is to translate the world’s most powerful genome editing technology into greatly needed products throughout the life sciences. Precision’s proprietary ARCUS genome editing technology enables the production of highly specific nucleases that can insert, remove, and modify DNA at essentially any location in a complex genome.